Designing successful clinical trials for rare diseases in 2024
Joan Busner, PhD, clinical vice president at Signant Health, tells sponsors to prioritise these five aspects when designing studies to investigate orphan drug treatments
Signant Health
How should EDC systems evolve to better serve modern clinical trials?
How to effectively incorporate PROMs in oncology trials
Scale management: What do sponsors and CROs need to consider?
How electronic clinical outcome assessments improve clinical trial evidence generation
How CATs can enhance clinical trials
Harnessing decentralised methods for trial optimisation
